Aldeyra annual meeting results: directors elected, auditor ratified, say-on-pay approved

Aldeyra Therapeutics, Inc.

Directors Nancy B. Miller-Rich (21.9M for, 12.6M withheld) and Ben R. Bronstein (22.7M for, 11.8M withheld) elected as Class I directors.
Shareholders ratified BDO USA as independent auditor for FY 2024: 44.1M for, 372.8K against, 186.6K abstain.
Non-binding advisory vote on named executive officer compensation approved: 31.5M for, 2.9M against, 126.6K abstain, 10.2M broker non-votes.
Total shares voted: 44,659,863 of 59,414,489 eligible (75.2% quorum).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.